Attacking pain at its source: new perspectives on opioids

Author(s): Stein C, Schafer M, Machelska H

Abstract

The treatment of severe pain with opioids has thus far been limited by their unwanted central side effects. Recent research promises new approaches, including opioid analgesics acting outside the central nervous system, targeting of opioid peptide–containing immune cells to peripheral damaged tissue, and gene transfer to enhance opioid production at sites of injury.

Similar Articles

Personality and the perception of health and happiness

Author(s): Cloninger CR, Zohar AH

J Pers Soc Psychol 54: 1063-1070

Author(s): Watson D, Clark LA, Tellegen A (1988a) Development and validation of brief measures of positive and negative affect: the PANAS scales

Cohort Profile: LifeLines, a three-generation cohort study and biobank

Author(s): Scholtens S, Smidt N, Swertz MA, Bakker SJ, Dotinga A, et al.

Pleasures of the brain

Author(s): Berridge KC

The pleasures of play: pharmacological insights into social reward mechanisms

Author(s): Trezza V, Baarendse PJJ, Vanderschuren LJMJ

The neuro-symphony of stress

Author(s): Joëls M, Baram TZ

Stereotype threat and social function in opioid substitution therapy patients

Author(s): Henry JD, von Hippel C, Terrett G, Mercuri K, McAlear K, et al.

Delta Opioid Receptor Signaling Promotes Resilience to Stress Under the Repeated Social Defeat Paradigm in Mice

Author(s): Henry MS, Bisht K, Vernoux N, Gendron L, Torres-Berrio A, et al.

Global Approaches in the Analysis of Cocaine-Induced Gene Expression

Author(s): Eipper-Mains JE, Eipper BA, Mains RE

Nicotine dependence is characterized by disordered reward processing in a network driving motivation

Author(s): Bühler M, Vollstädt-Klein S, Kobiella A, Budde H, Reed LJ, et al.

State-dependent µ-opioid Modulation of Social Motivation–a model

Author(s): Loseth GE, Ellingsen DM, Leknes S

Opioid system and human emotions

Author(s): Nummenmaa L, Tuominen L

Dynorphin, stress, and depression

Author(s): Knoll AT, Carlezon Jr WA

The role of the dynorphin/κ opioid receptor system in anxiety

Author(s): Hang Ai, Wang YJ, He L, Liu JG

Corticolimbic anatomical characteristics predetermine risk for chronic pain

Author(s): Vachon-Presseau E, Tétreault P, Petre B, Huang L, Berger SE, et al.

The Genome of the Netherlands: design, and project goals

Author(s): Boomsma DI, Wijmenga C, Slagboom EP, Swertz MA, Karssen LC, et al.

PLINK: a tool set for whole-genome association and population-based linkage analyses

Author(s): Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al.

Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes

Author(s): Albrechtsen A, Grarup N, Li Y, Sparsø T, Tian G, et al.

J Abnorm Psychol 97: 346-353

Author(s): Watson D, Clark LA, Carey G (1988b) Positive and negative affectivity and their relation to anxiety and depressive disorders

Modeling genetic imprinting effects of DNA sequences with multilocus polymorphism data

Author(s): Wen S1, Wang C, Berg A, Li Y, Chang MM, et al.

Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats

Author(s): Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, et al.

Psychotomimesis mediated by kappa opiate receptors

Author(s): Pfeiffer A, Brantl V, Herz A, Emrich HM

Fast and accurate genotype imputation in genome-wide association studies through pre-phasing

Author(s): Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR